Recommended content

Aurora Cannabis settles patent dispute with Willow Biosciences

Canadian licensed producer Aurora Cannabis has reached a settlement with Willow Biosciences over an ongoing patent litigation.

The settlement is confidential, according to Aurora, so few details are public.

ADVERTISEMENT

Aurora said it commenced the patent infringement action in July 2021.

The Alberta-based producer alleged that Willow’s biosynthetic process for synthesizing cannabinoids had infringed on Aurora’s patents, which are co-owned with the University of Saskatchewan and Canada’s National Research Council (NRC).

Aurora said the technology of the patents was invented by Jonathan Page, Anandia Labs co-founder and former chief science officer at Aurora, and his colleagues. The technology followed their work at the University of Saskatchewan and the NRC.

That research identified key enzymes and corresponding genes in the biosynthetic pathways of cannabis plants.

Aurora bought Anandia in 2018 in an all-stock deal valued at the time at roughly 115 million Canadian dollars ($85 million).

Aurora

Read full article on Marijuana Business Daily

Follow us on Instagram or join us on facebook page

Be first to rate

Marijuana Business Daily
Source

More news